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Abstract
The 2018 Varsity Medical Ethics debate convened upon the motion: “This house believes that the constant monitoring
of our health does more harm than good”. This annual debate between students from the Universities of Oxford and
Cambridge is now in its tenth year. This year’s debate was hosted at the Oxford Union on 8th of February 2018, with
Oxford winning for the Opposition, and was the catalyst for the collation and expansion of ideas in this paper.
New technological devices have the potential to enhance patient autonomy, improve patient safety, simplify the
management of chronic diseases, increase connectivity between patients and healthcare professionals and assist
individuals to make lifestyle changes to improve their health. However, these are pitted against an encroachment
of technology medicalising the individual and home, an exacerbation of health inequalities, a risk to the security
of patient data, an alteration of the doctor-patient relationship dynamic and an infringement on individual self-
identity. This paper will draw upon and develop these concepts, while contending arguments for and against
constant health monitoring. This is not a review of medical devices and health monitoring, but a reflective development
and more detailed elaboration of the main points highlighted in the 2018 Varsity Medical Ethics debate.
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Introduction
Technological breakthroughs have far reaching impacts
across society, with their benefits also permeating into
medicine. An exciting current development is the utilisa-
tion of smart phones in clinical practice, with this
termed mobile health (mHealth). Simultaneously,
devices continuously measuring health parameters are
being developed. Devices including those for continuous
glucose monitoring (CGM) are now being recommended
by the UK National Institute for Health and Clinical
Excellence (NICE), in certain circumstances [1]. Con-
stant health monitoring is already entering medical prac-
tice, making discussion of its ethical implications highly
relevant.
This paper will discuss personal health monitoring
(PHM), which refers to “any electronic device or system
that monitors and records data about a health-related
aspect of a person’s life outside a hospital setting” [2].
This will include devices used for diagnosis, specifically
the AliveCor KardiaMobile®, devices monitoring disease
states, including CGM, and devices used for contracep-
tion, of which we will focus on the app Natural Cycles®.
Additionally, we will discuss mHealth apps, such as
MyCOPD®, systems providing access to patient medical
records (PMRs) and wearable devices monitoring heart
rate and calorie usage, such as Fitbit® products, espe-
cially as these latter three are more ubiquitous as a
result of less stringent regulation. As these technologies
are highly varied, each shall be discussed in turn, with
the arguments in support and against their use
proposed.
Devices used for diagnosis
Personal health monitoring devices may be used by
patients to self-diagnose conditions, one example
being the AliveCor KardiaMobile®, a pocket-sized
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electrocardiogram (ECG) recorder. One of its pro-
claimed utilities is screening for atrial fibrillation
(AF). The UK is reportedly poor at diagnosing AF.
The British Journal of General Practice highlighted
the diagnosis gap in AF in 2016, with the diagnosed
prevalence being 1.6% in England while the modelled
estimates put real prevalence at 2.4% [3]. This leaves
a third of people with AF undiagnosed. It is estimated
that one in five strokes are a result of AF, while the
anticoagulant treatment available for AF could reduce
the risk of ischaemic stroke by about 70% [3]. Clearly
there is much to be desired here. The AliveCor Kar-
diaMobile® aims to reduce this diagnosis gap. It does
have impressive recorded sensitivity and specificity re-
sults [4] and an Australian study even suggested that
the device would be cost effective overall [5].
However, the Australian study does have one critical
shortcoming as highlighted by a NICE Medtech
innovation briefing [6]- it failed to compare the cost
effectiveness of the device to what could be achieved
through clinicians, or patients themselves, manually
palpating pulses more regularly [6]. As the first stage
of AF identification is through feeling an irregular
pulse, the requirement for an expensive monitoring
device is questionable; simply checking one’s pulse
could do the same role. This is the major drawback
of such devices designed for patient self-diagnosis:
they are expensive tools performing largely unre-
quired roles. Their use in clinical practice will depend
on them passing trials regarding their safety, efficacy
and cost effectiveness, similar to other medical
interventions.
Devices monitoring disease states
Continuously monitoring devices may simplify disease
management for patients. Taking diabetes as an
example, patients are required to adjust their insulin
dose according to their exercise levels, food intake
and if they show any signs of infection. CGM
removes the requirement for patients to repeatedly
pin-prick, making monitoring less burdensome. CGM
can have a more critical role in notifying patients
when their blood sugars are at dangerous levels,
potentially averting hypoglycaemic attacks which may
progress to coma and death, a powerful safety feature.
Additionally, devices continuously monitoring disease
may engage patients more in their treatment, enhan-
cing patient self-care and health.
On a broader analysis however, devices that constantly
record health parameters may result in patients develop-
ing increased anxiety through noting slight
non-pathological deviations from their baselines. This
hypothesis that constantly recording health parameters
may increase patient anxiety lacks validating evidence
however, and was not the case in a prospective rando-
mised trial on CGM [7]. The phenomenon of white coat
hypertension, an increase in blood pressure when re-
corded in the clinic, is counteracted by general practi-
tioners offering home kits for measuring blood pressure,
so personal monitoring devices are in fact used to re-
solve health-anxiety in this case.
As monitoring devices become more common place,
the consequences they will have on the social envir-
onment of patients must be sufficiently accounted for.
PHM results in greater medicalisation of the home
and personal life of individuals, with the term med-
icalisation referring to the encroachment of the clin-
ical sphere into matters non-medical. In this case,
medicalisation is a consequence of individuals acquir-
ing additional responsibility for their healthcare and
being required to utilise these medical devices con-
stantly, including in the home environment [2]. This
intrusion into the private life of a patient, so critical
for self-identity, must not be so readily dismissed.
Devices used for contraception
A more radical use of monitoring devices is perhaps
when they are used in place of existing medical inter-
ventions. This shift is occurring with contraception.
Contraception is far from a one-size-fits-all, with each
woman’s menstrual cycle individual and hormonal
contraception affecting this in equally idiosyncratic
ways. Natural Cycles®, a fertility tracking app, uses an
algorithm involving the woman’s temperature to esti-
mate whether or not she is fertile and gives advice on
whether or not she may need to use barrier contra-
ception. It holds the benefits of having no side-effects
and requiring no devices to be implanted. It has
gained approval from the European Medicines Agency
as a contraceptive with the efficacy rate for perfect
use of 99%, and 93% for typical use [8]. This com-
pares to only 91% as a combined statistic for typical
use of the oral contraceptive combined pill and
progestin-only pills [9].
Whilst Natural Cycles should be applauded for test-
ing efficacy and safety within the established regula-
tory framework, its use as a contraceptive should still
be seen in context. Long-acting reversible contracep-
tives, such as the coil, are still more efficacious and
oral contraceptive pills are more effective when used
perfectly with a failure rate of only 0.3% [9]. A con-
cern about the app is that it markets itself as a prod-
uct, similar to condom brands, unlike many other
methods of contraception which are accessible only
through healthcare professionals. For individuals to be
able to make an informed decision about their
contraceptive use, there ought to be clear guidance
readily available about each contraceptive option, and
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relevant healthcare professionals should be well
researched on novel devices used for contraception to
be able to provide women with accurate advice.
mHealth apps
Constant monitoring of health has clear benefits in the
management of chronic diseases, such as chronic
obstructive pulmonary disorder (COPD), asthma and
insulin-dependent diabetes. Patients with such diseases
are required to self-monitor their condition and carry
out their treatment regimen daily, being reviewed by a
health professional on an infrequent basis. mHealth apps
can reduce the mental workload associated with man-
aging chronic diseases by collating patients’ health infor-
mation into one place, acting as patient-centred hubs of
information. Apps containing medication diaries, educa-
tion pages and symptom trackers have been created and
NHS endorsed, with myCOPD® [10, 11] one such As
well as containing these facilities, this app includes vid-
eos on pulmonary rehabilitation and inhaler technique
enabling patients to seek clear, reliable help on any quer-
ies or concerns as they arise.
mHealth may also facilitate a quicker patient re-
sponse to any deviations from their health baseline
through promoting patient self-monitoring, with evi-
dence suggesting that self-monitoring reduces the
rates of hospital admissions [12]. Using the example
of COPD, when patients with severe COPD notice
increased breathlessness or green sputum production,
they are required to commence ‘rescue packs’ includ-
ing antibiotics with steroids. This targets an infection
as it develops, preventing too great a deterioration
and promoting a faster recovery. If mHealth apps
enhanced self-monitoring, they may result in these
treatment regimens being started more timely, further
improving patient care.
There is a risk however that mHealth may exacerbate
health inequalities. Some people from lower socioeco-
nomic groups may not be able to afford a mobile phone
capable of supporting the app’s function, therefore a shift
towards the uptake of mHealth would be excluding this
population group [13]. Such apps also disadvantage
those who are less tech-savvy, typically the elderly, lack-
ing the skills required to navigate the app in a product-
ive manner. Detailed and simple tutorials would be a
necessity, as well as simple user interfaces, to alleviate
this issue.
Telehealth
Schemes whereby monitoring results are sent to special-
ists have already been created and have been coined ‘tel-
ehealth’. One study analysed the effect of telehealth on
patients with COPD, heart failure and diabetes, where
patients recorded observations such as blood pressure
and blood glucose in their home [14]. This rather sim-
plistic intervention was associated with lower mortality
and emergency admission rates [14]. It may also give the
patient comfort and peace of mind to know their safety
is increased through constant monitoring from health-
care professionals [2].
A concern with such schemes is that there must be
stringent safeguards in place to protect the patient’s
medical information, as with all forms of digital storage
or transfer of sensitive healthcare information. Data se-
curity is thus regarded critical for protecting patient
privacy [2]. There are multiple ways by which digital
data may be accessed by third parties [13], not just for
telehealth yet for the digital storage of any information,
including data from monitoring devices mentioned pre-
viously for example. These include the hacking of data
sent over the internet or via Bluetooth, the legal seizing
of data by governmental bodies (such as use of sub-
poena) and access by telecommunication companies and
by cloud storage providers, including Internet service
provider (ISP) and Google, who may hold ownership of
data transmitted through their systems [13, 15]. This risk
is exacerbated by the potential for telecommunication
companies to then sell on the data they transfer. There
is another less complex way third parties may inadvert-
ently become aware of the individual’s health informa-
tion- simply glancing at the individual’s phone. The
security settings on the smartphone, app or device must
also be sufficient to ensure the data cannot be accessed
readily following theft of the device. It is of great con-
cern that a study found that some mHealth apps do not
even use any encryption when transferring data [15].
Patients must be made aware of these risks for consent
of data sharing to be valid, and they must also be in-
formed what will happen with their data if they later de-
cide to leave such a scheme [13]. Patients must also be
offered the highest possible degree of choice regarding
which aspects of their data are shared. Furthermore,
there must also be discussion on whether the patient
would like to be informed of any incidental findings
discovered in the analysis of the constant recordings of
their physiological parameters [13]. The complexity of
the consent process is heightened further when mobile
phones are used to record conversations or locations,
for example to examine the impact of Parkinson’s Dis-
ease on patients’ speech or their socialisation [16, 17], as
third parties who are in conversation with or meeting
the patients are inadvertently having their privacy
infringed upon, without consent.
There are additional concerns that telehealth may alter
the doctor patient dynamic [2]. The ability for healthcare
professionals to scrutinise the compliance of patients to
treatment regimens leads to a shift in power towards the
healthcare provider in any consultation [18]. It also
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questions whether the patient’s right to privacy is being
too readily forfeited. This fear may be partially alleviated
if sufficient consent processes are established, as men-
tioned previously. Another risk is that the use of tele-
health may further exacerbate social isolation of the
elderly, which may occur if PHM reduces the frequency
of visits made by human carers to patients [19].
Enabling access to digital patient medical records
Immediate access to patient medical records (PMRs)
is another arm of constant health monitoring. Sweden
has bold plans to enable electronic access to medical
records for all citizens over the age of 16 by 2020
[20]. The United Kingdom is following suit, with the
NHS also striving to become paperless and offer
digital access to patient files. These schemes may en-
hance the level of patient education and engagement
with their condition, and grant further autonomy to
the patient.
Providing access to PMRs is dogged with the same
hurdles of data security which have been discussed
previously in this article. Similar consent processes
with opt-in or opt-out options must be established to
ensure patients are informed of the relevant risks of
this data dissemination and have the option to accept
or reject them. There is the additional concern how-
ever, that patients will be provided with an undue
amount of information, without any training or edu-
cation on how to interpret it. The consequences of
misinterpretation may be significant, with this poten-
tially not only altering patients’ compliance with treat-
ment regimens, yet it may also have a psychological
impact on the individuals. Guidance ought therefore
to be issued for patients to help them understand the
contents of their medical records, or else the transfer
of autonomy to the patient is fictitious. The risk of
misinterpretation is even greater if instant access to
PMRs included access to test results prior to consul-
tations. It may also expound misinformation, if pa-
tients are drawn to ill-informed websites in an
attempt to understand what their test results mean
when lacking the advice of an experienced medical
professional. This potential outcome has generated
concern, particularly among some clinicians [21].
There has been some studies to investigate the evi-
dence of this assumption, and interestingly one study
of cancer patients’ attitudes found that patients would
prefer to find out results before consultations [22],
with other studies finding no increase in anxiety
following access to PMRs [23, 24]. Nonetheless, to
reduce the risks of misinformation and misinterpret-
ation, there must be a resolute effort to educate
patients on PMRs prior to the enabling of full and in-
stant access.
Wearable devices
Wearable devices are diverse in function, the breadth of
which was too expansive for the scope of this debate.
There are two areas which particularly warrant in depth
discussion. Firstly, whether fitness tracking wearable
devices are effective in driving lifestyle changes, and the
ethical implications for wearable devices such as fall
monitors for elderly individuals. These areas are quite
distinct, yet illustrate how practical and ethical consider-
ations are both critical for evaluating any such device.
Wearable devices on the general market claim to
encourage individuals to make lifestyle changes. At
the time of writing, the Fitbit® website asks the visitor
to “See how Fitbit can help you exercise, eat, sleep
and live better” [25] with the assumption being that
gaining data on these factors will help people strive
for their personal health goals. Two key studies have
analysed whether fitness trackers are able to deliver
the lifestyle improvements they claim. A study in
Singapore by Finkelstein et al., analysing the health
effects of the Fitbit Zip® noticed a decline in usage of
the device over the study period, with 40% of people
stopping usage within 6 months and 90% by a year
[26]. Before too readily drawing conclusions about
wearable devices from this, this trial used an
upper-arm sensor device which was discontinued in
2014, differing significantly from current wrist-worn
models [27], highlighting a problem in the method-
ology of clinical trials for such devices, as they may
be outdated and no longer accurately reflect the field
at the time of publishing. The users of fitness trackers
in the study did appear to have higher levels of activ-
ity after a year of use, yet the effect of this on health
is questionable as the study found that the Fitbit®
wearers did not have improved health outcomes re-
garding weight, blood pressure or heart rate. This was
not an overly large study, with only around 200
people in each intervention and control group, yet it
nonetheless fails to support that fitness trackers will
lead to improved health outcomes. Another study
(the IDEA clinical trial by Jakicic et al.,) was more
controversial, suggesting that fitness trackers may be
damaging [28]. The effect of standard weight loss
schemes was compared with the same schemes en-
hanced with a wearable device which provided the
user with feedback on their physical activity levels.
Surprisingly, it found that the group with the added
intervention of the wearable device lost less weight
over a 24 month time period. To understand why
these devices were unsuccessful in clinical trials, there
is a requirement for the field to investigate in more
detail what the proposed ‘mechanisms of action’ for
lifestyle modifying wearable devices are. One com-
monly cited potential mechanism may be through
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providing feedback on how the individual is meeting
health goals, yet its validity requires more detailed in-
vestigation. Therefore, at present it is unclear how
such wearable devices are proposed to work, and if
they have any effect on health at all. More specific
studies are required, with one example being an
ongoing study investigating whether a doctor or fam-
ily member supervising the activity levels of a
wearable-device user may provide a greater incentive
for increasing activity levels [29]. Such studies provide
more insight and will enable the field to progress.
The ethical considerations for wearable devices include
whether they influence patient autonomy, whether they
can lead to stigma, and whether there is an infringement
of privacy through ‘covert monitoring’. These concepts
may be well illustrated with fall monitors for elderly
individuals, utilised principally to enhance user safety.
Addressing the first concept, a reliance on PHM may
risk an erosion of individual autonomy [2]. To clarify
with an example, elderly patients dependent on fall
monitors may become less self-reliant, and with this
there may be a reduced sense of self-determination or
ability to choose to take risks [2]. Secondly, wearing any
device may alter the individual’s perception of them-
selves, or others’ perception of them. A group study of
elderly individuals in residential care found that partici-
pants were concerned that using technological devices
to assist with frailty would lead to a perception of them
being frail [30]. The development of this stigma may be
a result of wearing an embodiment of the illness [2].
This need not be visible however; their perception of the
stigma may lead to the individual altering their
self-identity, even if the wearable device is concealed. If
they consider themselves to be frail for example, they
may then self-impose pressure to act according to their
image of frailty [2]. Thirdly, the concept of covert moni-
toring must be addressed. The presence of monitoring
devices in the homes of individuals may be forgotten
over time. This would be particularly prominent when
the individual concerned has dementia. Monitoring an
individual who is unaware it is occurring raises concerns
regarding consent [31], which may extend to inadvert-
ently monitoring guests at the home of an individual
with monitoring equipment. These three ethical con-
cerns are substantial and cannot simply be dismissed in
the pursuit of greater safety for individuals.
Conclusion
“Doing all those boring things you do to stay healthy
may or may not make you live longer. However, I am
sure of one thing; it will make your life seem longer”
[32]. This may no longer be the case with techno-
logical advances simplifying self-monitoring and col-
lating all the data in one place, the smartphone.
These measures will greatly assist patients with
chronic diseases who already have to self-manage
their condition daily, for the rest of their lives. We
must hold fast however to ensure that the rights of
citizens are not violated in the pursuit of less trouble-
some disease management. Data security protocols
can be poorly adhered to within the NHS [33], the
consent processes for data sharing are in their infancy
and the effect of PHM on the individual and their
home environment is inadequately established. These
technological systems cannot ethically be permitted if
they require forfeit of the privacy of patient data by
transferring it across insecure data networks. These
risks are too evident for policy makers to feign ignor-
ance of this Orwellian assault on civil liberties. We
cannot allow the monitoring of health to lead to a
situation where patient health records, treatment and
even their whereabouts are held ownership by
tech-giants, telecommunication companies, the state,
or are freely available for all interested parties. Any
introduction of medical devices into healthcare must
be matched with increased patient education as to
their benefits and risks. Their effectiveness must be
established, as occurs for all medical treatments, and
addressing ethical concerns should be further inte-
grated into the development process of these devices.
Yes, technological advancement may well enhance
patient care, yet they will harm the identity of the in-
dividual if these shortfalls are not addressed.
About the debate
Following persuasive arguments from both sides, the
panel of judges declared the Oxford team (opposition)
victorious. The Cambridge team focused their argu-
ment on the risks of medicalisation, the exacerbation
of health inequalities and the potential for patient
misinterpretation of PMRs and data collected by
monitoring devices. The Oxford team countered these
points and further highlighted how constant health
monitoring may increase patient safety through en-
hancing compliance with treatment regimens and
identifying patient deterioration faster. The Oxford
team emphasised how these may reduce hospital ad-
missions and improve patient care. Most contention
arose on the app Natural Cycles®, and whether it is
beneficial for women as a side-effect free contracep-
tive option, or if instead it is a risk by advertising it-
self on a platform apart from medical professionals.
Following the debate, the teams resolved this by
agreeing that women should be offered the option of
Natural Cycles®, yet clear guidance should be issued
from health bodies, placing it in context alongside the
other contraceptive options. This is a note which res-
onated throughout our discussions, that the risks of
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medical devices must be transparent for patients and
healthcare bodies, and that there is an onus on device
developers and regulatory bodies to protect patients’
rights of safety, consent and privacy.
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